LDS/Medical Tests/ADAMTS2 Gene Mutation Analysis

ADAMTS2 Gene Mutation Analysis

The ADAMTS2 gene is located on the long (q) arm of chromosome 5 at position 35.3. This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family who share distinct protein domains such as propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. The encoded preproprotein is proteolytically processed to generate the mature procollagen N-proteinase or ADAMTS2 enzyme.

ADAMTS2 mutations cause Ehlers-Danlos syndrome type VIIC or Dermatosparaxis Ehlers-Danlos syndrome (dEDS), an autosomally recessively inherited connective-tissue disorder, characterized by extreme skin fragility, characteristic facies, joint laxity, lax skin, umbilical hernia and blue sclera. dEDS is extremely rare and only a few cases have been reported in the literature. Individuals with dEDS have reduced production or activity of the ADAMTS2 enzyme, which excises the N-propeptide of the fibrillar procollagens types I-III and type V. Abnormalities in the enzyme lead to improper formation of collagen and weakening of connective tissues.

  • Aids in the diagnosis of Dermatosparaxis Ehlers-Danlos Syndrome,
  • Pre-natal carrier screening

Normal:

  • Negative for mutation analyzed or no pathogenic variants detected

Abnormal:

  • Usually reported as heterozygous (if variation detected on one allele) or homozygous if variants detected on both alleles.
  • If heterozygous variation detected, indicates carrier
  • If homozygous variant detected, indicate affected/diseased

Negative for mutation analyzed (no pathogenic variants detected)

Bidirectional sequencing of the entire coding region and intron/exon boundaries of the ADAMTS2 gene. ADAMTS2 gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods include quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.

Whole Blood, bone marrow, skin/tissue biopsy, cultured fibroblasts, buccal swab, DNA.

Stability (depends on specimen)

Blood:

  • Ambient: 3-5 days
  • Refrigerated: 7 days
Ehlers-Danlos Syndrome Panel (multi Genes), Next-Generation Sequencing and Deletion/Duplication Analysis, Fluorescence in Situ Hybridization (FISH), immunohistochemical analysis, biochemical test from cultured fibroblasts, histopathological examination.
2-3 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login